DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02102882
Contributor : Dominique Chadeyron <>
Submitted on : Wednesday, April 17, 2019 - 5:24:39 PM
Last modification on : Friday, April 19, 2019 - 1:33:59 AM

Links full text

Identifiers

Collections

Citation

Ian Flinn, Carole Miller, Kirit Ardeshna, Scott Tetreault, Sarit Assouline, et al.. DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma. Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (11), pp.912-922. ⟨10.1200/JCO.18.00915⟩. ⟨hal-02102882⟩

Share

Metrics

Record views

11